InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.44
(
-0.50%
)
US TECH 100
18,566.40
(
1.45%
)
Dow Jones
40,743.33
(
0.50%
)
Brent Oil
80.03
(
1.86%
)
Bitcoin
65,981.62
(
-0.28%
)
Post# of 252749
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

xavierprivas

Send PM Follow Ignore
Followers 6
Posts 162
Boards Moderated 0
Alias Born 09/14/2009

xavierprivas

Re: north40000 post# 198317

Thursday, 12/17/2015 7:07:55 AM

Thursday, December 17, 2015 7:07:55 AM

Post# of 252749
Look like GLPG got a better deal than with Abbvie.
Abbvie could not afford to do both their internal drug ABT-494
and GLPG so they chose their own drug ABT-494. Thus they
returned their rights to filgotinib back to GLPG.

IMO ABT-494 is not as good as GLPG filgotinib.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up